A new experimental drug called ION224 may offer a breakthrough against MASH, a serious fatty liver disease linked to obesity and diabetes. By blocking a fat-producing liver enzyme, the treatment significantly improved liver health in clinical trials without major side effects. Credit: Shutterstock A drug designed to shut down fat production inside the liver could become a major new weapon against one of the world's fastest-growing liver diseases. Researchers at University of California San